Back to results
US 2025/0145570 A1Published application
Dhodh inhibitor polymorph
OwnerRobert MOOREinventor
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to physical forms of a DHODH inhibitor, such as a stable crystalline form of and compositions comprising the same. Also provided is the use of the physical form (such as a polymorph) or composition thereof in treatment, such as the treatment of a viral disease or an autoimmune disease or disorder.
Claims17
1-18. (canceled)
A polymorph of 2-(3,5-difluoro-3′methoxybiphenyl-4-ylamino)nicotinic acid, which is a DHODH inhibitor, characterised by a X-ray powder diffraction pattern comprising the following peaks in terms of degrees of 2-theta at approximately:
- 9.129±0.1, 17.375±0.1, 20.708±0.1, 25.274±0.1, 26.488±0.1 and 29.041±0.1.
Dependencies are inferred from the claim text.